Symbols / XAGE $0.40 +14.29%
XAGE Chart
About
Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth factors, cytokines, peptides, and other small molecules involved in the body's natural healing process. The company also develops a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Corporation and changed its name to Longevity Health Holdings, Inc. in March 2025. Longevity Health Holdings, Inc. was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.
Fundamentals
Scroll to Statements| Sector | Consumer Defensive | Industry | Household & Personal Pro | Market Cap | 712.70K |
| Enterprise Value | 222.10K | Income | -5.74M | Sales | 1.46M |
| Book/sh | -2.23 | Cash/sh | 0.62 | Dividend Yield | — |
| Payout | 0.00% | Employees | 15 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 0.49 | P/B | -0.18 | P/C | — |
| EV/EBITDA | -0.04 | EV/Sales | 0.15 | Quick Ratio | 0.21 |
| Current Ratio | 0.42 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -5.10 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | 19.75% | Earnings | — | ROA | -119.32% |
| ROE | — | ROIC | — | Gross Margin | 82.77% |
| Oper. Margin | -3.51% | Profit Margin | 0.00% | Shs Outstand | 1.78M |
| Shs Float | 1.67M | Short Float | 0.59% | Short Ratio | 0.27 |
| Short Interest | — | 52W High | 9.30 | 52W Low | 0.25 |
| Beta | 0.36 | Avg Volume | 2.15K | Volume | 25.00 |
| Target Price | — | Recom | None | Prev Close | $0.35 |
| Price | $0.40 | Change | 14.29% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.40
Latest analyst target
3. DCF / Fair value
$-27.49
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.40
Low
—
High
—
Mean
—
- New Longevity Health chief takes equity stake to lead acquisition push - Stock Titan ue, 17 Mar 2026 12
- Longevity Health Holdings Raises $200,000 in Private Placement With International Capital Partners - TradingView ue, 17 Mar 2026 12
- Longevity Health (OTCQB: XAGE) raises $200K and installs Ram Ajjarapu as CEO - Stock Titan ue, 17 Mar 2026 12
- Longevity Health Appoints New CEO Amid Strategic Shift - TipRanks ue, 17 Mar 2026 13
- Longevity Health Holdings, Inc. Announces Chief Executive Officer Changes, Effective March 16, 2026 - marketscreener.com ue, 17 Mar 2026 18
- Breakout Move: Can XAGE continue delivering strong returns - Quarterly Risk Review & Verified Momentum Stock Alerts - baoquankhu1.vn ue, 17 Mar 2026 17
- Longevity Health to combine with 20/20 BioLabs in all-stock deal - MSN Sat, 07 Mar 2026 14
- What is the current Price Target and Forecast for Longevity Health Holdings, Inc. (XAGE) - Zacks Investment Research Wed, 16 Jul 2025 01
- Why did XAGE Stock Surge in Today’s Premarket Trading? - Tokenist ue, 15 Jul 2025 07
- Longevity Health to acquire THPlasma in all-stock merger - Investing.com Mon, 14 Jul 2025 07
- Longevity Health Holdings Announces Business Updates - Yahoo Finance hu, 15 May 2025 07
- Longevity Health Holdings Announces Continued Nasdaq Listing to Complete Merger With 20/20 Biolabs - GlobeNewswire Wed, 21 May 2025 07
- Longevity Health Holdings to remain listed on Nasdaq ahead of planned merger - The Business Journals hu, 22 May 2025 07
- Longevity Health Soars On Merger Deal With True Health - RTTNews ue, 15 Jul 2025 07
- Longevity Health Holdings, Inc. Announces Reverse Stock Split | XAGE Stock News - Stock Titan Mon, 12 May 2025 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 5000 | 2336 | — | Purchase at price 0.47 per share. | UPTON RICHARD A. | Director | — | 2024-09-13 00:00:00 | D |
| 1 | 475 | 218 | — | Purchase at price 0.46 per share. | CASSADAY BRYAN J | Chief Financial Officer | — | 2024-09-10 00:00:00 | D |
| 2 | 1261 | 643 | — | Purchase at price 0.51 per share. | STURGEON PATRICK A | Director | — | 2024-09-06 00:00:00 | I |
| 3 | 1260 | 643 | — | Purchase at price 0.51 per share. | GREGORY KATHRYN | Director | — | 2024-09-06 00:00:00 | I |
| 4 | 1009 | 515 | — | Purchase at price 0.51 per share. | FRISCH SCOTT M. | Director | — | 2024-09-06 00:00:00 | I |
| 5 | 1009 | 515 | — | Purchase at price 0.51 per share. | SPENLEHAUER GILLES | Director | — | 2024-09-06 00:00:00 | I |
| 6 | 109 | 62 | — | Purchase at price 0.57 per share. | STURGEON PATRICK A | Director | — | 2024-08-30 00:00:00 | I |
| 7 | 109 | 62 | — | Purchase at price 0.57 per share. | GREGORY KATHRYN | Director | — | 2024-08-30 00:00:00 | I |
| 8 | 87 | 50 | — | Purchase at price 0.57 per share. | FRISCH SCOTT M. | Director | — | 2024-08-30 00:00:00 | I |
| 9 | 87 | 50 | — | Purchase at price 0.57 per share. | SPENLEHAUER GILLES | Director | — | 2024-08-30 00:00:00 | I |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -51.71K | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.01 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -4.76M | -5.02M | -5.25M | -1.66M |
| TotalUnusualItems | -5.75M | -10.17M | 194.59K | -2.08M |
| TotalUnusualItemsExcludingGoodwill | -5.75M | -10.17M | 194.59K | -2.08M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -10.65M | -16.21M | -9.05M | -6.48M |
| ReconciledDepreciation | 197.26K | 124.79K | 242.56K | 242.12K |
| ReconciledCostOfRevenue | 6.36K | 0.00 | ||
| EBITDA | -10.50M | -15.19M | -5.06M | -3.74M |
| EBIT | -10.70M | -15.32M | -5.30M | -3.98M |
| NetInterestIncome | -49.02K | -889.32K | -3.75M | -2.50M |
| InterestExpense | 49.02K | 889.32K | 3.75M | 2.50M |
| NormalizedIncome | -4.96M | -6.04M | -9.25M | -4.40M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -10.37M | -15.45M | -9.05M | -6.48M |
| TotalExpenses | 5.05M | 5.22M | 5.51M | 1.94M |
| TotalOperatingIncomeAsReported | -5.00M | -5.94M | -5.51M | -1.94M |
| DilutedAverageShares | 712.09K | 367.37K | 641.21K | 641.21K |
| BasicAverageShares | 712.09K | 367.37K | 641.21K | 641.21K |
| DilutedEPS | -14.70 | -43.80 | -14.98 | -10.58 |
| BasicEPS | -14.70 | -43.80 | -14.98 | -10.58 |
| DilutedNIAvailtoComStockholders | -10.37M | -16.12M | -9.61M | -6.79M |
| NetIncomeCommonStockholders | -10.37M | -16.12M | -9.61M | -6.79M |
| PreferredStockDividends | 676.02K | 556.50K | 307.93K | |
| NetIncome | -10.37M | -15.45M | -9.05M | -6.48M |
| NetIncomeIncludingNoncontrollingInterests | -10.37M | -15.45M | -9.05M | -6.48M |
| NetIncomeDiscontinuousOperations | 282.20K | 760.16K | 0.00 | |
| NetIncomeContinuousOperations | -10.65M | -16.21M | -9.05M | -6.48M |
| TaxProvision | -97.28K | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -10.75M | -16.21M | -9.05M | -6.48M |
| OtherIncomeExpense | -5.70M | -10.10M | 205.52K | -2.04M |
| OtherNonOperatingIncomeExpenses | 44.80K | 68.77K | 10.92K | 37.38K |
| SpecialIncomeCharges | -44.58K | -726.28K | -1.06M | 438.18K |
| OtherSpecialCharges | 44.58K | 1.06M | -438.18K | |
| RestructuringAndMergernAcquisition | 0.00 | 726.28K | 0.00 | |
| GainOnSaleOfSecurity | -5.70M | -9.44M | 1.26M | -2.52M |
| NetNonOperatingInterestIncomeExpense | -49.02K | -889.32K | -3.75M | -2.50M |
| TotalOtherFinanceCost | 2.04M | 1.78M | ||
| InterestExpenseNonOperating | 49.02K | 889.32K | 3.75M | 2.50M |
| OperatingIncome | -5.00M | -5.22M | -5.51M | -1.94M |
| OperatingExpense | 5.04M | 5.22M | 5.51M | 1.94M |
| DepreciationAmortizationDepletionIncomeStatement | 83.49K | 97.11K | 94.30K | 94.16K |
| DepreciationAndAmortizationInIncomeStatement | 83.49K | 97.11K | 94.30K | 94.16K |
| Amortization | 83.49K | 97.11K | ||
| AmortizationOfIntangiblesIncomeStatement | 83.49K | 97.11K | ||
| ResearchAndDevelopment | 1.05M | 2.50M | 2.20M | 982.84K |
| SellingGeneralAndAdministration | 3.90M | 2.62M | 3.22M | 863.33K |
| SellingAndMarketingExpense | 189.32K | 0.00 | ||
| GeneralAndAdministrativeExpense | 3.72M | 2.62M | 3.22M | 863.33K |
| OtherGandA | 3.72M | 2.62M | 3.22M | 863.33K |
| GrossProfit | 43.96K | 0.00 | ||
| CostOfRevenue | 6.36K | 0.00 | ||
| TotalRevenue | 50.32K | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 90.83K | 0.00 | 0.00 | 0.00 |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 696.85K | 769.69K | 641.21K | 641.21K |
| ShareIssued | 696.85K | 769.69K | 641.21K | 641.21K |
| NetDebt | 84.02K | 2.65M | 8.59M | |
| TotalDebt | 638.99K | 2.14M | 3.74M | 9.69M |
| TangibleBookValue | -4.73M | 24.72M | -37.82M | -29.61M |
| InvestedCapital | -4.47M | 26.04M | -35.01M | -20.97M |
| WorkingCapital | -4.92M | 24.40M | -6.69M | -15.62M |
| NetTangibleAssets | -4.73M | 24.72M | -37.82M | -29.61M |
| CapitalLeaseObligations | 397.83K | 847.85K | 957.23K | 1.08M |
| CommonStockEquity | -4.71M | 24.75M | -37.79M | -29.58M |
| PreferredStockEquity | 1.00 | |||
| TotalCapitalization | -4.71M | 24.75M | -37.79M | -29.58M |
| TotalEquityGrossMinorityInterest | -4.71M | 24.75M | -37.79M | -29.58M |
| StockholdersEquity | -4.71M | 24.75M | -37.79M | -29.58M |
| RetainedEarnings | -68.87M | -58.50M | -42.38M | -32.77M |
| AdditionalPaidInCapital | 64.16M | 83.25M | 4.59M | 3.16M |
| CapitalStock | 2.09K | 2.31K | 897.00 | 36.92K |
| CommonStock | 2.09K | 2.31K | 897.00 | 36.92K |
| PreferredStock | 0.00 | 1.00 | 0.00 | |
| TotalLiabilitiesNetMinorityInterest | 6.19M | 39.20M | 39.54M | 31.13M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 309.94K | 697.72K | 32.24M | 15.33M |
| PreferredSecuritiesOutsideStockEquity | 0.00 | 31.42M | 14.33M | |
| DerivativeProductLiabilities | 0.00 | 33.30K | ||
| LongTermDebtAndCapitalLeaseObligation | 309.94K | 697.72K | 827.73K | 962.83K |
| LongTermCapitalLeaseObligation | 309.94K | 697.72K | 827.73K | 961.91K |
| LongTermDebt | 922.00 | |||
| CurrentLiabilities | 5.88M | 38.50M | 7.30M | 15.80M |
| OtherCurrentLiabilities | 29.87M | 826.98K | 3.84M | |
| CurrentDebtAndCapitalLeaseObligation | 329.06K | 1.44M | 2.91M | 8.72M |
| CurrentCapitalLeaseObligation | 87.90K | 150.14K | 129.50K | 120.16K |
| CurrentDebt | 241.16K | 1.29M | 2.78M | 8.60M |
| OtherCurrentBorrowings | 241.16K | 1.29M | 2.78M | 8.60M |
| PensionandOtherPostRetirementBenefitPlansCurrent | 0.00 | 1.29M | 916.93K | 489.79K |
| PayablesAndAccruedExpenses | 5.55M | 5.90M | 2.64M | 2.75M |
| CurrentAccruedExpenses | 1.49M | 1.48M | 505.36K | 1.88M |
| InterestPayable | 1.18M | 1.18M | 477.72K | 1.88M |
| Payables | 4.06M | 4.42M | 2.14M | 871.31K |
| AccountsPayable | 4.06M | 4.42M | 2.14M | 871.31K |
| TotalAssets | 1.47M | 63.95M | 1.75M | 1.56M |
| TotalNonCurrentAssets | 518.43K | 1.05M | 1.14M | 1.38M |
| GoodwillAndOtherIntangibleAssets | 19.64K | 24.19K | 28.70K | 33.22K |
| OtherIntangibleAssets | 19.64K | 24.19K | 28.70K | 33.22K |
| NetPPE | 498.79K | 1.02M | 1.11M | 1.35M |
| AccumulatedDepreciation | -701.65K | -622.72K | -530.12K | -440.33K |
| GrossPPE | 1.20M | 1.65M | 1.64M | 1.79M |
| Leases | 115.33K | 115.33K | 115.33K | 115.33K |
| OtherProperties | 1.08M | 1.53M | 1.53M | 1.67M |
| MachineryFurnitureEquipment | 3.58K | 3.58K | 3.58K | 0.00 |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 955.55K | 62.90M | 605.54K | 178.70K |
| OtherCurrentAssets | 28.18K | |||
| HedgingAssetsCurrent | 0.00 | 5.70M | 0.00 | |
| AssetsHeldForSaleCurrent | 0.00 | 53.32M | 0.00 | |
| CurrentDeferredAssets | 86.31K | 0.00 | 394.15K | 166.34K |
| PrepaidAssets | 297.46K | 761.27K | 55.07K | 0.00 |
| Inventory | 108.70K | 0.00 | ||
| Receivables | 305.93K | 204.56K | 0.00 | |
| TaxesReceivable | 301.84K | 204.56K | 0.00 | |
| AccountsReceivable | 4.10K | 0.00 | ||
| CashCashEquivalentsAndShortTermInvestments | 157.14K | 2.91M | 128.15K | 12.36K |
| CashAndCashEquivalents | 157.14K | 2.91M | 128.15K | 12.36K |
| CashFinancial | 157.14K | 2.91M | 128.15K | 12.36K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -4.39M | -8.38M | -3.44M | -1.18M |
| RepurchaseOfCapitalStock | 0.00 | -2.29K | 0.00 | |
| RepaymentOfDebt | -714.18K | -3.20M | 0.00 | |
| IssuanceOfDebt | 495.69K | 1.86M | 2.75M | 1.12M |
| IssuanceOfCapitalStock | 2.69M | 0.00 | 1.06M | 3.19K |
| CapitalExpenditure | -30.47K | -7.16K | -7.27K | |
| InterestPaidSupplementalData | 29.47K | 283.53K | 92.59K | 0.00 |
| IncomeTaxPaidSupplementalData | 0.00 | 750.00K | 0.00 | 0.00 |
| EndCashPosition | 157.14K | 2.91M | 128.15K | 12.36K |
| BeginningCashPosition | 2.91M | 128.15K | 12.36K | 1.15K |
| ChangesInCash | -2.76M | 2.78M | 115.79K | 11.21K |
| FinancingCashFlow | 2.38M | 11.16M | 3.55M | 1.20M |
| CashFlowFromContinuingFinancingActivities | 2.38M | 11.16M | 3.55M | 1.20M |
| NetOtherFinancingCharges | -86.31K | 12.46M | -402.55K | -166.34K |
| ProceedsFromStockOptionExercised | 0.00 | 41.07K | 146.22K | 234.16K |
| NetPreferredStockIssuance | 0.00 | 1.06M | 0.00 | |
| PreferredStockIssuance | 0.00 | 1.06M | 0.00 | |
| NetCommonStockIssuance | 2.69M | 0.00 | -2.29K | 3.19K |
| CommonStockPayments | 0.00 | -2.29K | 0.00 | |
| CommonStockIssuance | 2.69M | 0.00 | 0.00 | 3.19K |
| NetIssuancePaymentsOfDebt | -218.49K | -1.34M | 2.75M | 1.12M |
| NetShortTermDebtIssuance | -218.49K | -1.34M | 2.75M | 1.12M |
| ShortTermDebtPayments | -714.18K | -3.20M | 0.00 | |
| ShortTermDebtIssuance | 495.69K | 1.86M | 2.75M | 1.12M |
| NetLongTermDebtIssuance | 2.75M | 1.12M | ||
| LongTermDebtIssuance | 2.75M | 1.12M | ||
| InvestingCashFlow | -748.80K | -30.47K | -7.16K | -7.27K |
| CashFlowFromContinuingInvestingActivities | -748.80K | -30.47K | -7.16K | -7.27K |
| NetBusinessPurchaseAndSale | -748.80K | 0.00 | ||
| PurchaseOfBusiness | -748.80K | 0.00 | ||
| NetPPEPurchaseAndSale | 0.00 | -30.47K | -7.16K | -7.27K |
| PurchaseOfPPE | 0.00 | -30.47K | -7.16K | -7.27K |
| OperatingCashFlow | -4.39M | -8.35M | -3.43M | -1.18M |
| CashFlowFromContinuingOperatingActivities | -4.39M | -8.35M | -3.43M | -1.18M |
| ChangeInWorkingCapital | 669.49K | -3.42M | 2.34M | 952.69K |
| ChangeInOtherWorkingCapital | -124.84K | -115.13K | ||
| ChangeInOtherCurrentLiabilities | -2.61M | -20.99M | -124.84K | -115.13K |
| ChangeInOtherCurrentAssets | 4.66M | 18.97M | -28.18K | 500.00 |
| ChangeInPayablesAndAccruedExpense | -1.64M | -534.47K | 2.55M | 1.06M |
| ChangeInAccruedExpense | -1.28M | 460.84K | 1.49M | 977.58K |
| ChangeInInterestPayable | 0.00 | -109.38K | 1.06M | 715.49K |
| ChangeInPayable | -359.14K | -995.31K | 1.06M | 80.32K |
| ChangeInAccountPayable | -359.14K | -449.87K | 1.06M | 80.32K |
| ChangeInTaxPayable | 0.00 | -545.44K | 0.00 | |
| ChangeInIncomeTaxPayable | 0.00 | -545.44K | 0.00 | |
| ChangeInPrepaidAssets | 463.81K | -659.93K | -55.07K | 9.42K |
| ChangeInInventory | -108.70K | 0.00 | ||
| ChangeInReceivables | -101.38K | -204.56K | 0.00 | |
| ChangesInAccountReceivables | -4.10K | 0.00 | ||
| OtherNonCashItems | -1.41M | 285.51K | 2.60M | 1.35M |
| StockBasedCompensation | 827.04K | 667.68K | 636.37K | 246.80K |
| DepreciationAmortizationDepletion | 197.26K | 124.79K | 242.56K | 242.12K |
| DepreciationAndAmortization | 197.26K | 124.79K | 242.56K | 242.12K |
| AmortizationCashFlow | 83.49K | 97.11K | 4.52K | 4.52K |
| AmortizationOfIntangibles | 83.49K | 97.11K | 4.52K | 4.52K |
| Depreciation | 113.77K | 27.68K | 238.04K | 237.61K |
| OperatingGainsLosses | 5.70M | 9.44M | -194.59K | 2.52M |
| GainLossOnInvestmentSecurities | 5.70M | 9.44M | -1.26M | 2.52M |
| NetIncomeFromContinuingOperations | -10.37M | -15.45M | -9.05M | -6.48M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for XAGE
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|